| PERIOD ENDING | 29-Feb-08 | 31-Dec-01 | 30-Sep-01 | 30-Jun-01 | | Total Revenue | 5 | 9,328 | 10,564 | 11,118 | | Cost of Revenue | 4 | 4,443 | 4,883 | 5,283 | | | Gross Profit | 1 | 4,885 | 5,681 | 5,835 | | | Operating Expenses | | Research Development |
-
| 4,759 | 14,426 |
-
| | Selling General and Administrative | 1,372 | 4,614 | (3,748) | 9,764 | | Non Recurring |
-
| 319 | 281 | 3,473 | | Others |
-
| 3,196 | 4,042 | 621 | | | | Total Operating Expenses |
-
| 12,888 | 15,001 |
-
| | | | Operating Income or Loss | (1,371) | (8,003) | (9,320) | (8,023) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (1,591) | (5,116) | 1,056 | | Earnings Before Interest And Taxes | (1,371) | (9,594) | (14,436) | (6,967) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,371) | (9,594) | (14,436) | (6,967) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,371) | (9,594) | (14,436) | (6,967) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,371) | (9,594) | (14,436) | (6,967) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,371) | ($9,594) | ($14,436) | ($6,967) |
|
0.07% Nasdaq 
0.37%
Income Statement
